What are the treatment options for managing eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Eczema

Topical corticosteroids are the mainstay of treatment for eczema and should be used as first-line therapy, with the least potent preparation required to control symptoms, supplemented by emollients, avoidance of triggers, and appropriate treatment of secondary infections. 1

First-Line Treatment Approach

Avoidance of Triggers

  • Avoid soaps and detergents that remove natural skin lipids
  • Use dispersible creams as soap substitutes
  • Avoid extremes of temperature
  • Keep nails short to prevent scratching damage
  • Wear cotton clothing instead of irritant materials like wool 1

Bathing and Emollients

  • Regular bathing helps with cleansing and hydrating the skin
  • Apply emollients after bathing when they are most effective
  • Emollients provide a surface lipid film that reduces water loss from the epidermis 1

Topical Corticosteroids

Topical corticosteroids form the cornerstone of eczema management:

  1. Potency selection:

    • Use the least potent preparation required to control symptoms
    • Very potent and potent preparations should be used with caution and for limited periods
    • For mild-moderate eczema, mild to moderate potency is often sufficient 1
  2. Application guidelines:

    • Apply once or twice daily (once daily is often sufficient)
    • Some newer preparations require only once-daily application
    • Avoid long-term continuous use, especially on sensitive areas 1, 2
  3. Common pitfall: Fear of topical steroids often leads to undertreatment. Patient education about proper use and safety is essential to ensure adequate treatment. 1

Secondary Treatment Options

Topical Calcineurin Inhibitors (TCIs)

  • Tacrolimus 0.1% is among the most effective treatments, comparable to potent topical steroids 3, 4
  • Particularly useful for sensitive sites (face, neck, genital areas) 2
  • Pimecrolimus is also effective but should be used with caution
  • Important safety note: Should be avoided on malignant or pre-malignant skin conditions 5

Tar Preparations

  • Ichthammol (1% in zinc ointment) is less irritant than coal tar
  • Useful for lichenified eczema, especially when applied as paste bandages
  • Coal tar solution (1%) is generally preferred to crude coal tar 1

Antihistamines

  • Primarily useful for their sedative properties during severe pruritic flares
  • Should be used as short-term adjuvant to topical treatment
  • Non-sedating antihistamines have little value in eczema management
  • May develop tachyphylaxis with prolonged use 1, 2

Management of Complications

Infection Management

  1. Bacterial infections:

    • Flucloxacillin is first-line for Staphylococcus aureus (most common pathogen)
    • Phenoxymethylpenicillin for β-hemolytic streptococci
    • Erythromycin for penicillin-allergic patients or resistant cases 1
  2. Viral infections:

    • Eczema herpeticum requires prompt treatment with oral acyclovir
    • Use intravenous acyclovir for ill, febrile patients 1

Advanced Therapies for Refractory Cases

Newer Topical Options

  • JAK inhibitors (ruxolitinib 1.5%, delgocitinib 0.5%) rank among the most effective treatments in recent studies 3, 4
  • PDE-4 inhibitors (crisaborole, roflumilast) are available but generally less effective than potent TCS or TCIs 3, 4

Systemic Therapy

  • Reserved for severe, refractory cases after failure of topical treatments
  • Systemic corticosteroids have a limited but definite role in severe cases
  • Should not be used for maintenance treatment 1

Monitoring and Safety Considerations

Local Adverse Effects

  • Application site reactions: Most common with tacrolimus 0.1% and crisaborole 2%, least common with topical steroids 3, 4
  • Skin thinning: No evidence of increased risk with short-term TCS use, but may occur with longer-term use (6-60 months) 3, 4
  • Pituitary-adrenal suppression: Risk increases with potent/very potent steroids, especially with occlusion or extensive use 1

Special Populations

  • Children: Use lower potency steroids when possible
  • Sensitive areas: Use mild steroids or TCIs on face, neck, and genital areas
  • Immunocompromised patients: Safety and efficacy of some treatments like pimecrolimus have not been established 5

Treatment Algorithm

  1. Mild eczema:

    • Daily emollients
    • Mild topical corticosteroids for flares
    • Avoidance of triggers
  2. Moderate eczema:

    • Daily emollients
    • Moderate potency topical corticosteroids for body
    • TCIs or mild steroids for face/sensitive areas
    • Consider antihistamines for severe itching
  3. Severe eczema:

    • Daily emollients
    • Potent topical corticosteroids for short periods
    • TCIs for maintenance and sensitive areas
    • Consider referral for systemic therapy if inadequate response

Remember that under-treatment is a common problem in eczema management. The "get control then keep control" approach using appropriate potency topical treatments is recommended for optimal outcomes 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical anti-inflammatory treatments for eczema: network meta-analysis.

The Cochrane database of systematic reviews, 2024

Research

Topical Anti-Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta-Analysis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.